Alumis ALMS
NASDAQ ALMS
$6.40 -0.15 (-2.29%)
As of: Nov 10, 2026 · 3:59 PM EST

Alumis (ALMS) EBT Margin (2025 - 2026)

Updated

Alumis (ALMS) posted EBT Margin of -8662.94% for Q2 2026, down 10566.91 percentage points from 1903.98% a year earlier.

Analysis

Alumis (ALMS) EBT Margin (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT Margin at Alumis was -3567.24%; for FY2025, it was -1047.34%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.13%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 27.75%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.74%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 29.63%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 18.19%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 45.21%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 36.90%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 20.41%
10 Alumis 830.27 Mn -881.19 Mn - -8,662.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,662.94%
Dec 31, 2025 -4,817.57%
Sep 30, 2025 -5,360.70%
Jun 30, 2025 1,903.98%
Mar 31, 2025 -583.49%
API Access

Alumis EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY